Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Nicola A Hanania, Suzanne C. Lareau & Barbara P. Yawn. (2017) Safety of inhaled long-acting anti-muscarinic agents in COPD. Postgraduate Medicine 129:5, pages 500-512.
Read now
Read now
Masakazu Ichinose, Hiroyuki Taniguchi, Ayako Takizawa, Lars Grönke, Lazaro Loaiza, Florian Voß, Yihua Zhao & Yoshinosuke Fukuchi. (2016) The efficacy and safety of combined tiotropium and olodaterol via the Respimat® inhaler in patients with COPD: results from the Japanese sub-population of the Tonado® studies. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 2017-2027.
Read now
Read now
Girolamo Pelaia, Alessandro Vatrella, Maria Teresa Busceti, Luca Gallelli, Cecilia Calabrese, Rosa Terracciano, Nicola Lombardo & Rosario Maselli. (2015) Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD. Therapeutics and Clinical Risk Management 11, pages 1563-1572.
Read now
Read now
Wijdan H Ramadan, Wissam K Kabbara, Ghada M El Khoury & Sarah A Al Assir. (2015) Combined bronchodilators (tiotropium plus olodaterol) for patients with chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 2347-2356.
Read now
Read now
Articles from other publishers (1)
S. N. Avdeev. (2016) Symptoms and quality of life in patients with chronic obstructive pulmonary disease: are there patient_defined outcomes or predictive factors?. PULMONOLOGIYA 26:2, pages 231-237.
Crossref
Crossref